Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SARNP | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | MEF2D | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | KIF5B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | SCAMP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SH3YL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | NIT2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ADSS | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LMO2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | PPP2R5D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | CPN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |